Jpmorgan Chase & CO Landec Corp \Ca\ Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11,396 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,396
Previous 10,296 10.68%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
N/A
1,100 Added 10.68%
11,396 $0
Q3 2024

Nov 08, 2024
BUY
N/A
1,100 Added 10.68%
11,396 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-1,100 Reduced 9.65%
10,296 $0
Q2 2024

Aug 12, 2024
BUY
N/A
6,931 Added 205.97%
10,296 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-8,031 Reduced 70.47%
3,365 $0
Q1 2024

May 10, 2024
BUY
N/A
1,922 Added 133.19%
3,365 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-9,953 Reduced 87.34%
1,443 $0
Q4 2023

Feb 12, 2024
BUY
N/A
57 Added 4.11%
1,443 $0
Q3 2023

Nov 14, 2023
BUY
N/A
254 Added 22.44%
1,386 $0
Q2 2023

Aug 11, 2023
SELL
N/A
-18,939 Reduced 94.36%
1,132 $0
Q1 2023

May 18, 2023
BUY
N/A
20,071 New
20,071 $0
Q4 2022

Feb 13, 2023
BUY
$0.0 - $9.95 $0 - $46,018
4,625 Added 32.3%
18,942 $123,000
Q3 2022

Nov 14, 2022
BUY
$8.57 - $11.57 $2,648 - $3,575
309 Added 2.21%
14,317 $127,000
Q2 2022

Aug 11, 2022
BUY
$8.84 - $11.64 $15,408 - $20,288
1,743 Added 14.21%
14,008 $140,000
Q1 2022

May 11, 2022
SELL
$10.07 - $11.93 $189,054 - $223,973
-18,774 Reduced 60.49%
12,265 $142,000
Q4 2021

Feb 10, 2022
SELL
$7.95 - $11.24 $215,810 - $305,121
-27,146 Reduced 46.65%
31,039 $344,000
Q3 2021

Nov 12, 2021
BUY
$9.22 - $12.44 $536,465 - $723,821
58,185 New
58,185 $536,000

Others Institutions Holding LNDC

# of Institutions
80
Shares Held
20.5M
Call Options Held
65.8K
Put Options Held
14.1K
View Full List

About LANDEC CORP \CA\

LNDC Quotes by TradingView
  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email